File Download
  Patent History
  • Application
    ZL201080054710.2 2010-12-06
  • Granted
    CN 102753581 2012-10-24
Supplementary

granted patent: Antl-igf-ir antibodies and uses thereof

TitleAntl-igf-ir antibodies and uses thereof
Granted PatentCN 102753581
Granted Date2012-10-24
Priority Date2010-12-06 PCT/CN2010001963
2009-12-04 US 12/266681P
Inventors
Issue Date2012
Citation
China Patent CN 102753581. Beijing, PRC: State Intellectual Property Office (SIPO) of the P.R.C., 2012 How to Cite?
AbstractThe subject invention provides antibodies, or binding fragments thereof, that specifically bind to human IGF-IR. Also provided are nucleic acid molecules encoding the antibodies and binding fragments of the subject invention and vectors and host cells containing these nucleic acid molecules. The disclosure also provides methods of inhibiting cancer cell growth and metastasis in a mammal using the antibodies described herein, as well as compositions containing the antibodies, nucleic acid molecules encoding the antibodies, and host cells and vectors comprising the nucleic acid molecules. The disclosure also features the use of the polypeptides to detect the presence of IGF-IR in a mammal, and epitopes that can be used as cancer vaccine immunogens.
Persistent Identifierhttp://hdl.handle.net/10722/221222

 

DC FieldValueLanguage
dc.date.accessioned2015-11-05T03:51:27Z-
dc.date.available2015-11-05T03:51:27Z-
dc.date.issued2012-
dc.identifier.citationChina Patent CN 102753581. Beijing, PRC: State Intellectual Property Office (SIPO) of the P.R.C., 2012-
dc.identifier.urihttp://hdl.handle.net/10722/221222-
dc.description.abstractThe subject invention provides antibodies, or binding fragments thereof, that specifically bind to human IGF-IR. Also provided are nucleic acid molecules encoding the antibodies and binding fragments of the subject invention and vectors and host cells containing these nucleic acid molecules. The disclosure also provides methods of inhibiting cancer cell growth and metastasis in a mammal using the antibodies described herein, as well as compositions containing the antibodies, nucleic acid molecules encoding the antibodies, and host cells and vectors comprising the nucleic acid molecules. The disclosure also features the use of the polypeptides to detect the presence of IGF-IR in a mammal, and epitopes that can be used as cancer vaccine immunogens.-
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License for public patent documents-
dc.titleAntl-igf-ir antibodies and uses thereof-
dc.typePatent-
dc.identifier.authorityZHANG MEIYUN=rp01409-
dc.description.naturepublished_or_final_version-
dc.contributor.inventorZHANG MEIYUN-
patents.identifier.applicationZL201080054710.2-
patents.identifier.applicationCN 2010854710-
patents.identifier.grantedCN 102753581-
patents.description.assigneeUNIV HONG KONG -
patents.description.countryChina, PRC-
patents.date.granted2012-10-24-
patents.identifier.hkutechidAIDS-2009-00339-2-
patents.date.application2010-12-06-
patents.date.priority2010-12-06 PCT/CN2010001963-
patents.date.priority2009-12-04 US 12/266681P-
patents.description.cccn-
patents.relation.familyEP 2507263 (A1) 2012-10-10 -
patents.relation.familyUS 2011135663 (A1) 2011-06-09 -
patents.relation.family U S8444982 (B2) 2013-05-21-
patents.relation.familyWO 2011066721 (A1) 2011-06-09-
patents.description.kindA-
patents.typePatent_granted-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats